The Auτonomy Study is a collaboration between kiːelements and Janssen, focused on evaluating the safety and effectiveness of an investigational medicine for early Alzheimer’s Disease.
This project in collaboration with MS-Zentrum Dresden and Roche aims to examine connections between speech and the three leading symptoms of Multiple Sclerosis: cognition, fatigue, and depression.